Telesis Bio, Inc. (TBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0220
0.00 (0.00%)
Aug 14, 2025, 8:00 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Collaboration | 8.69M | Log In | Log In | Log In | Log In |
Collaboration Growth | 30.68% | Log In | Log In | Log In | Log In |
BioXP Systems | 6.55M | Log In | Log In | Log In | Log In |
BioXP Systems Growth | -1.57% | Log In | Log In | Log In | Log In |
Services | 6.23M | Log In | Log In | Log In | Log In |
Services Growth | -23.08% | Log In | Log In | Log In | Log In |
BioXP Kits | 3.20M | Log In | Log In | Log In | Log In |
BioXP Kits Growth | 8.48% | Log In | Log In | Log In | Log In |
Royalties and Other | 2.84M | Log In | Log In | Log In | Log In |
Royalties and Other Growth | 3.13% | Log In | Log In | Log In | Log In |
Benchtop Reagents | - | Log In | Log In | Log In | Log In |
Benchtop Reagents Growth | - | Log In | Log In | Log In | Log In |
Synthetic Biology Instruments, Reagents and Associated Products | - | Log In | Log In | Log In | Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
North America | 12.31M | Log In | Log In | Log In | Log In |
North America Growth | 56.62% | Log In | Log In | Log In | Log In |
Europe/ Middle East/ Africa | 2.24M | Log In | Log In | Log In | Log In |
Europe/ Middle East/ Africa Growth | 46.45% | Log In | Log In | Log In | Log In |
Asia Pacific | 1.44M | Log In | Log In | Log In | Log In |
Asia Pacific Growth | -5.85% | Log In | Log In | Log In | Log In |
United States | - | Log In | Log In | Log In | Log In |